Welcome to LookChem.com Sign In|Join Free

CAS

  • or

352514-21-7

Post Buying Request

352514-21-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

352514-21-7 Usage

Description

2(1H)-Pyridinone,6-(hydroxymethyl)-(9CI) is a versatile chemical compound belonging to the class of pyridinones. It is a derivative of pyridine with a hydroxymethyl group attached to the sixth position of the pyridinone ring. This unique structural feature endows it with potential applications in various fields, including medicinal chemistry, drug discovery, and the synthesis of pharmaceuticals, agrochemicals, and other fine chemicals.

Uses

Used in Pharmaceutical Industry:
2(1H)-Pyridinone,6-(hydroxymethyl)-(9CI) is used as a building block in organic synthesis for the preparation of various pharmaceuticals. Its unique structural features make it a promising candidate for the development of new drugs and therapeutic agents.
Used in Agrochemical Industry:
In the agrochemical industry, 2(1H)-Pyridinone,6-(hydroxymethyl)-(9CI) is utilized as a key intermediate in the synthesis of agrochemicals, contributing to the development of effective and environmentally friendly pest control solutions.
Used in Fine Chemicals Industry:
2(1H)-Pyridinone,6-(hydroxymethyl)-(9CI) serves as a valuable intermediate in the production of other complex organic molecules, particularly in the fine chemicals industry. Its versatility allows for its use in the synthesis of a wide range of specialty chemicals with diverse applications.
Used in Medicinal Chemistry and Drug Discovery:
Due to its unique structural features, 2(1H)-Pyridinone,6-(hydroxymethyl)-(9CI) has potential applications in medicinal chemistry and drug discovery. It can be employed as a starting material or intermediate in the development of novel therapeutic agents with improved efficacy and selectivity.
Overall, 2(1H)-Pyridinone,6-(hydroxymethyl)-(9CI) is a promising chemical compound with a wide range of applications across various industries, making it an essential component in the development of innovative products and solutions.

Check Digit Verification of cas no

The CAS Registry Mumber 352514-21-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,5,2,5,1 and 4 respectively; the second part has 2 digits, 2 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 352514-21:
(8*3)+(7*5)+(6*2)+(5*5)+(4*1)+(3*4)+(2*2)+(1*1)=117
117 % 10 = 7
So 352514-21-7 is a valid CAS Registry Number.

352514-21-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 6-(hydroxymethyl)-1H-pyridin-2-one

1.2 Other means of identification

Product number -
Other names 6-(hydroxymethyl)pyridin-2-ol

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:352514-21-7 SDS

352514-21-7Downstream Products

352514-21-7Relevant articles and documents

ADENOSINE RECEPTOR BINDING COMPOUNDS

-

Paragraph 00544-00545, (2020/02/06)

The present invention relates to pharmaceutical compounds and compositions of Formula (I) and methods of treatment using the compounds and compositions, especially for the treatment and/or prevention of a proliferation disorder, such as cancer. Compounds of Formula (I) as further described herein are shown modulators of the adenosine A2A receptor and exhibit antiproliferative activity. Accordingly, these compounds are useful to treat proliferative disorders such as cancer, and other adenosine receptor-related conditions including an inflammatory disease, renal disease, diabetes, vascular disease, lung disease, or an autoimmune disease.

BENZOXAZINONE DERIVATIVES FOR THE TREATMENT OF GLYTL MEDIATED DISORDERS

-

Page/Page column 112, (2011/02/24)

The present invention relates to benzoxazinone derivatives, processes for their preparation, pharmaceutical compositions and medicaments containing them and to their use in treating disorders mediated by GlyT1, including neurological and neuropsychiatric disorders, in particular psychoses, dementia or attention deficit disorder.

Novel pleuromutilin derivatives

-

, (2008/06/13)

Pleuromutilin compounds of the formula (A) and (B) are of use in anti-bacterial therapy.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 352514-21-7